James David Sullivan

CIK: 0001834436

Transaction Breakdown

Open Market Buys (P)1 (16.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BKYI

BIO KEY INTERNATIONAL INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

BKYI
BIO KEY INTERNATIONAL INC
Jun 30, 2026
Award(A)
Direct
250 shares at avg. $3.83$957.5
BKYI
BIO KEY INTERNATIONAL INC
Dec 31, 2025
Award(A)
Direct
2.5K shares at avg. $0.46$1K
BKYI
BIO KEY INTERNATIONAL INC
Sep 2, 2025
Award(A)
Direct
40K shares-
BKYI
BIO KEY INTERNATIONAL INC
Aug 22, 2025
Purchase(P)
Direct
10K shares at avg. $0.77$8K
BKYI
BIO KEY INTERNATIONAL INC
Jun 30, 2025
Award(A)
Direct
139 shares at avg. $0.70$97.3
BKYI
BIO KEY INTERNATIONAL INC
Dec 31, 2024
Award(A)
Direct
139 shares at avg. $1.40$194.6

		Type	Shares	Price		Ownership
Jun 30, 2026	BKYI BIO KEY INTERNATIONAL INC	Award(A)	250	$3.83	$958	Direct
Dec 31, 2025	BKYI BIO KEY INTERNATIONAL INC	Award(A)	2,500	$0.46	$1,150	Direct
Sep 2, 2025	BKYI BIO KEY INTERNATIONAL INC	Award(A)	40,000	-	-	Direct
Aug 22, 2025	BKYI BIO KEY INTERNATIONAL INC	Purchase(P)	10,000	$0.77	$7,700	Direct
Jun 30, 2025	BKYI BIO KEY INTERNATIONAL INC	Award(A)	139	$0.70	$97	Direct
Dec 31, 2024	BKYI BIO KEY INTERNATIONAL INC	Award(A)	139	$1.40	$195	Direct

1-6 of 6 transactions

About Sullivan James David

Sullivan James David (SEC CIK 0001834436) files insider reports with the SEC as Chief Legal Officer of BIO KEY INTERNATIONAL INC (BKYI).

Signal8 holds 6 ownership filings by Sullivan James David, all Form 4s, filed between Jan 3, 2025 and Jul 2, 2026. Those filings report 6 transactions, from Dec 31, 2024 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sullivan James David's filings is in HOLMDEL, NJ.

Recent filings by Sullivan James David

Jun 30, 2026: Grant or award of BKYI shares (Form 4, code A).
Dec 31, 2025: Grant or award of BKYI shares (Form 4, code A).
Sep 2, 2025: Grant or award of BKYI shares (Form 4, code A).
Aug 22, 2025: Open-market purchase of BKYI shares (Form 4, code P).
Jun 30, 2025: Grant or award of BKYI shares (Form 4, code A).

Other insiders filing for BIO KEY INTERNATIONAL INC (BKYI)

DEPASQUALE MICHAEL W, Chief Executive Officer
LACOUS MIRA K, Chief Technology Officer
Welch Cecilia C, Chief Financial Officer
Kwok Fong Wong, Managing Director, BIO-key HK
Alia Emmanuel, Director
Michel Robert J, Director

How to read Form 4 transaction codes